2023 Lipid Nanoparticles development Europe Summit

With lipid nanoparticles moving beyond mRNA vaccines, biopharma are racing against the clock to exploit clinical utility to deliver more complex payloads, while optimising scalability and product quality.

Micropore will be again participating in this 3-day summit together with 100+ senior leaders, sharing exclusive data to help maximise this non-viral delivery system's potential. The 2nd Lipid Nanoparticle Development Europe Summit is committed to equipping participants with actionable takeaways across end-to-end characterisation, biodistribution, formulation and scale up to supercharge LNP pipeline development with therapeutic promise for patients.